Clinical trial · Interventional
Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this prospective, interventional, non-randomized study was to compare pain score in unilateral and bilateral posterior percutaneous neurolytic celiac plexus block (NCPB) in upper abdominal cancer patients. The main questions it aimed to answer are: 1. Whether unilateral or bilateral NCPB technique has a better pain relief 2. Was there any difference in terms of complication rates between these two approaches All participants were having upper abdominal cancer whether operated or non-operable cancer were given a unilateral or bilateral neurolytic celiac plexus block. Pain scores and adverse events at multiple time points post-procedure were recorded.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Abdominal Cancer | Malignant Abdominal Neoplasm | ALIAS | 0.90 |
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
| Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bilateral Neurolytic Celiac Plexus Block with Absolute Alcohol | Drug | — | UNRESOLVED |
| Unilateral Neurolytic Celiac Plexus Block with Absolute Alcohol | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Unilateral Approach Group
- description
- Patients in this group have received a unilateral percutaneous posterior approach for NCPB. The procedure was performed under fluoroscopic guidance
- interventionNames
- Drug: Unilateral Neurolytic Celiac Plexus Block with Absolute Alcohol
- type
- ACTIVE_COMPARATOR
- label
- Bilateral Approach Group
- description
- Patients in this group have undergone a bilateral percutaneous posterior approach for NCPB, following the same procedural guidance.
- interventionNames
- Drug: Bilateral Neurolytic Celiac Plexus Block with Absolute Alcohol
Primary outcomes (1)
- measure
- Pain Score using the Visual Analog Scale
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * All upper abdominal malignancy adult patients * on palliative care, * having a visual analog scale (VAS) of more than 7 Exclusion Criteria: * Patients on anti-coagulant medications, * having an INR \> 1.50 and or * Platelets count \< 80000, * inability to provide informed consent, or * those who have previously undergone celiac plexus intervention.
References
Publications (0)
Data not yet available